126 related articles for article (PubMed ID: 33901818)
21.
Higgins EM; Bos JM; Dotzler SM; John Kim CS; Ackerman MJ
Circ Genom Precis Med; 2019 Nov; 12(11):e002648. PubMed ID: 31638832
[TBL] [Abstract][Full Text] [Related]
22. Generation of a human iPSC line (MPIi007-A) from a patient with Metachromatic leukodystrophy.
Kim KP; Yoon J; Kim J; Röpke A; Shin B; Wook Han D; Greber B; Schöler HR
Stem Cell Res; 2020 Oct; 48():101993. PubMed ID: 32950023
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a human induced pluripotent stem cell line (SDQLCHi037-A) from a patient with Alagille syndrome carrying heterozygous mutation in JAG1 gene.
Wang B; Yang L; Li Y; Gao M; Zhang H; Yang X; Guan J; Liu Y; Gai Z
Stem Cell Res; 2021 Mar; 51():102162. PubMed ID: 33465531
[TBL] [Abstract][Full Text] [Related]
24. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
25. Establishment of a human iPSC line (SDQLCHi010-A) from a patient with optic nerve malformation carrying a heterozygous mutation in PAX6 gene.
Zhang H; Ma Y; Yu S; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
Stem Cell Res; 2019 Dec; 41():101611. PubMed ID: 31707209
[TBL] [Abstract][Full Text] [Related]
26. An integration-free iPSC line (MUSIi008-A) derived from a patient with severe hemolytic anemia carrying compound heterozygote mutations in KLF1 gene for disease modeling.
Potirat P; Wattanapanitch M; Viprakasit V; Kheolamai P; Issaragrisil S
Stem Cell Res; 2019 Jan; 34():101344. PubMed ID: 30605837
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a non-integrate iPS cell line CSUASOi002-A, from urine-derived cells of a female patient with macular corneal dystrophy carrying compound heterozygous CHST6 mutations.
Jing Y; Zhou Y; Wang C; Liu J; Guo Y; Mao S; Chan HF; Tang S; Chen J
Stem Cell Res; 2019 Dec; 41():101598. PubMed ID: 31669782
[TBL] [Abstract][Full Text] [Related]
29. Establishment of human induced pluripotent stem cell line SDQLCHi029-A from one Type 1 familial glucocorticoid deficiency patient carrying compound heterozygote mutations in MC2R gene.
Zhang H; Liu C; Liu Y; Gai Z
Stem Cell Res; 2024 Apr; 76():103368. PubMed ID: 38430736
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a human induced pluripotent stem cell line (SDQLCHi005-A) from a patient with mastocytosis carrying heterozygous mutation in KIT gene.
Zhang H; Ma Y; Yan B; Yang X; Li Y; Guan J; Dong R; Liu Y; Gai Z
Stem Cell Res; 2019 Oct; 40():101565. PubMed ID: 31522012
[TBL] [Abstract][Full Text] [Related]
31. Generation of two induced pluripotent stem cell (iPSC) lines from X-linked adrenoleukodystrophy (X-ALD) patients with adrenomyeloneuropathy (AMN).
Son D; Quan Z; Kang PJ; Park G; Kang HC; You S
Stem Cell Res; 2017 Dec; 25():46-49. PubMed ID: 29065337
[TBL] [Abstract][Full Text] [Related]
32. Generation of urine-derived iPS cell line via a non-integrative method from a Barth syndrome patient with TAZ gene mutation.
Guo X; Wang L; Chen K; Song S; Wang X; Gu X; Niu C; Chu M
Stem Cell Res; 2020 Jun; 47():101886. PubMed ID: 32619718
[TBL] [Abstract][Full Text] [Related]
33. [Gene mutation and clinical phenotype analysis of patients with Noonan syndrome and hypertrophic cardiomyopathy].
Liu XH; Ding WW; Han L; Liu XR; Xiao YY; Yang J; Mo Y
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):780-784. PubMed ID: 29050118
[No Abstract] [Full Text] [Related]
34. Generation of an induced pluripotent stem cell line BIOi002-A from a patient with autosomal dominant optic atrophy.
Zhang XH; Xie Y; Xu K; Li Y
Stem Cell Res; 2021 May; 53():102278. PubMed ID: 33752025
[TBL] [Abstract][Full Text] [Related]
35. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations.
Denayer E; Devriendt K; de Ravel T; Van Buggenhout G; Smeets E; Francois I; Sznajer Y; Craen M; Leventopoulos G; Mutesa L; Vandecasseye W; Massa G; Kayserili H; Sciot R; Fryns JP; Legius E
Genes Chromosomes Cancer; 2010 Mar; 49(3):242-52. PubMed ID: 19953625
[TBL] [Abstract][Full Text] [Related]
36. Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier.
McLenachan S; Zhang D; Zhang X; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Fletcher S; Chen FK
Stem Cell Res; 2019 Jan; 34():101357. PubMed ID: 30611018
[TBL] [Abstract][Full Text] [Related]
37. A Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c.4082G>A mutation, ISMMSi002-B, for disease modeling.
Klein S; Dvornik JL; Yarrabothula AR; Schaniel C
Stem Cell Res; 2017 Aug; 23():73-76. PubMed ID: 28925368
[TBL] [Abstract][Full Text] [Related]
38. Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype?
Brasil AS; Malaquias AC; Wanderley LT; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):717-22. PubMed ID: 21340158
[TBL] [Abstract][Full Text] [Related]
39. Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation.
Zarate YA; Lichty AW; Champion KJ; Clarkson LK; Holden KR; Matheus MG
J Child Neurol; 2014 Aug; 29(8):NP13-7. PubMed ID: 23877478
[TBL] [Abstract][Full Text] [Related]
40. Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.
Kobayashi T; Aoki Y; Niihori T; Cavé H; Verloes A; Okamoto N; Kawame H; Fujiwara I; Takada F; Ohata T; Sakazume S; Ando T; Nakagawa N; Lapunzina P; Meneses AG; Gillessen-Kaesbach G; Wieczorek D; Kurosawa K; Mizuno S; Ohashi H; David A; Philip N; Guliyeva A; Narumi Y; Kure S; Tsuchiya S; Matsubara Y
Hum Mutat; 2010 Mar; 31(3):284-94. PubMed ID: 20052757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
